Skip to main content
Signal8

Chou William

SEC insider (Form 3/4/5 filer). CIK 0001949693. PRESIDENT AND CEO at Passage BIO, Inc. (PASG). 5 reported Form 4/5 transactions since Sep 2024; latest on Mar 16, 2026. Located in PHILADELPHIA, PA.

Companies Chou William has filed insider reports for

  • Passage BIO, Inc. (PASG): Director, Officer, PRESIDENT AND CEO
Chou William profile photo

Chou William

CIK: 0001949693

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Passage BIO, Inc. logo
PASG

Passage BIO, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Mar 16, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    58K shares-
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Jan 8, 2026
    Exercise
    Direct
    10K shares-
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Jan 8, 2026
    Sale
    Direct
    4.1K shares at avg. $18.44$75K
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Mar 15, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    779.5K shares-
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Jan 15, 2025
    Award

    Restricted Stock Unit

    Direct
    20K shares-

1-5 of 5